Patents by Inventor Joel Jessee

Joel Jessee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemically Defined Serum Albumin Substitutes
    Publication number: 20240043794
    Abstract: Provided herein, inter alia, are chemically defined components and compositions that substitute or partially substitute for albumin in cell culture media. The components and compositions may support cell cultures, protect cells, or enhance viability of cultured cells. Further provided are chemically defined culture media supplements for use in cell culture media containing albumin. The chemically defined culture media supplements may rescue cells from albumin-induced toxicity.
    Type: Application
    Filed: December 15, 2021
    Publication date: February 8, 2024
    Inventors: Joel JESSEE, David KUNINGER, Soojung SHIN
  • Plant virus movement proteins and methods of using same
    Patent number: 11866723
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Grant
    Filed: January 20, 2020
    Date of Patent: January 9, 2024
    Assignee: MOLECULAR TRANSFER INC.
    Inventors: Gulilat Gebeyehu, Joel Jessee
  • Lipid Compositions For In Vivo Delivery
    Publication number: 20240000966
    Abstract: Provided herein, are compositions, methods and kits for inducing an immune response in a subject. In aspects, a lipid composition is described, which includes at least one ionizable lipid comprising a charge (N), at least one peptide, and a nucleic acid molecule comprising a charge (P). In aspects, methods are provided for delivery of a payload to an immune cell using a lipid composition comprising at least one ionizable lipid, at least one endosomal release peptide, and a payload.
    Type: Application
    Filed: June 29, 2023
    Publication date: January 4, 2024
    Inventors: Evgenia VEROVSKAYA, Joel JESSEE
  • TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
    Publication number: 20220090141
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Application
    Filed: August 9, 2021
    Publication date: March 24, 2022
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • POL YCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20210323984
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: April 5, 2021
    Publication date: October 21, 2021
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • Transfection complexes and methods of using the same
    Patent number: 11085056
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: August 10, 2021
    Assignee: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat Gebeyehu, Joel Jessee
  • AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20210189433
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 24, 2021
    Inventors: Joel JESSEE, Gulilat GEBEYEHU
  • Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
    Patent number: 10968240
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: April 6, 2021
    Assignee: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat Gebeyehu, Joel Jessee
  • Agents for improved delivery of nucleic acids to eukaryotic cells
    Patent number: 10883118
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: January 5, 2021
    Assignee: Molecular Transfer Inc.
    Inventors: Joel Jessee, Gulilat Gebeyehu
  • PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME
    Publication number: 20200283795
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Application
    Filed: January 20, 2020
    Publication date: September 10, 2020
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • Plant virus movement proteins and methods of using the same
    Patent number: 10538784
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: January 21, 2020
    Assignee: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat Gebeyehu, Joel Jessee
  • POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20190352316
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: December 17, 2018
    Publication date: November 21, 2019
    Applicant: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20190264230
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: November 21, 2018
    Publication date: August 29, 2019
    Inventors: Joel Jessee, Gulilat Gebeyehu
  • Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
    Patent number: 10155780
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes. The present invention is in the field of molecular biology, and more particularly in the field of transfection, which utilizes new compounds and methods for the introduction of nucleic acids into eukaryotic cells.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: December 18, 2018
    Assignee: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat Gebeyehu, Joel Jessee
  • Agents for improved delivery of nucleic acids to eukaryotic cells
    Patent number: 10138497
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: November 27, 2018
    Assignee: Molecular Transfer, Inc.
    Inventors: Joel Jessee, Gulilat Gebeyehu
  • AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20180002724
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: September 18, 2017
    Publication date: January 4, 2018
    Inventors: Joel Jessee, Gulilat Gebeyehu
  • Agents for improved delivery of nucleic acids to eukaryotic cells
    Patent number: 9765359
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: September 19, 2017
    Assignee: Molecular Transfer, Inc.
    Inventors: Joel Jessee, Gulilat Gebeyehu
  • PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING THE SAME
    Publication number: 20170253888
    Abstract: Disclosed herein are transfection complexes comprising at least one cell surface ligand; at least one helper lipid component; and a transfection enhancer. Also disclosed are pharmaceutical compositions comprising the disclosed transfection complexes, and a pharmaceutically acceptable carrier. Further, disclosed are methods of transfecting a cell, the method comprising the steps of: obtaining a transfection complex as disclosed; and contacting a cell with the transfection complex.
    Type: Application
    Filed: March 1, 2017
    Publication date: September 7, 2017
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20170029448
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes. The present invention is in the field of molecular biology, and more particularly in the field of transfection, which utilizes new compounds and methods for the introduction of nucleic acids into eukaryotic cells.
    Type: Application
    Filed: October 28, 2013
    Publication date: February 2, 2017
    Applicant: MOLECULAR TRANSFER, INC.
    Inventors: Gulilat GEBEYEHU, Joel JESSEE
  • AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
    Publication number: 20160130607
    Abstract: New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 12, 2016
    Inventors: Joel Jessee, Gulilat Gebeyehu